Agabawi Salem
Department of Internal Medicine, Section of Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Internal Medicine, Section of Infectious Diseases, King AbdulAziz University, Jeddah, Saudi Arabia.
Case Rep Infect Dis. 2019 Dec 11;2019:4289502. doi: 10.1155/2019/4289502. eCollection 2019.
Drug-induced aseptic meningitis is a rare medical condition with trimethoprim-sulfamethoxazole being one of the most common antimicrobial agents associated with it. Here, I report a case of a 56-year-old male who presented to a health care facility with shock and meningitis-like syndrome in two occasions, one year apart following an exposure to trimethoprim-sulfamethoxazole for treatment of skin/soft tissue infection. Investigations did not reveal an infectious etiology in the two presentations. The patient improved with supportive care and withdrawal of the offending agent. In the two admissions, the patient improved following stopping the offending drug in addition to supportive care. The diagnosis of trimethoprim-sulfamethoxazole-induced aseptic meningitis was the most likely explanation for this case. Trimethoprim-sulfamethoxazole-induced aseptic meningitis is rare although it is a life-threatening side effect of TMP/SMX; therefore, the clinicians should keep the diagnosis of drug-induced aseptic meningitis in the differential diagnosis of aseptic meningitis in the appropriate clinical setting as early withdrawal of the culprit drug and supportive measurements will lead to early recovery.
药物性无菌性脑膜炎是一种罕见的医学病症,甲氧苄啶-磺胺甲恶唑是与之相关的最常见抗菌药物之一。在此,我报告一例56岁男性病例,该患者在因皮肤/软组织感染接受甲氧苄啶-磺胺甲恶唑治疗后,分别于相隔一年的两次就诊时出现休克和类脑膜炎综合征。两次就诊时的检查均未发现感染病因。患者通过支持治疗和停用致病药物后病情好转。在两次入院治疗中,除支持治疗外,患者停用致病药物后病情均有改善。甲氧苄啶-磺胺甲恶唑所致无菌性脑膜炎最有可能是该病例的病因。尽管甲氧苄啶-磺胺甲恶唑所致无菌性脑膜炎是TMP/SMX的一种危及生命的副作用,但却很罕见;因此,临床医生在适当的临床环境中进行无菌性脑膜炎鉴别诊断时应考虑药物性无菌性脑膜炎的诊断,因为尽早停用致病药物和采取支持措施将有助于早期康复。